MONITORING OF VARIOUS TYPES OF NEUROMUSCULAR BLOCKADE
https://doi.org/10.21292/2078-5658-2016-13-6-64-71
Abstract
Goal of the review: to build up the current understanding of electrophysiological specific features of various neuromuscular blockades. Having analyzed the results of multiple studies devoted to investigation of the impact of various medications including inhalation anesthetics on the neuromuscular neurility, the authors summarized the current opportunities to monitor neuromuscular blockade. It has been noted that the data for blockade monitoring when using traditional neuromuscular blocking agents are studied much better compared to the drugs providing the other types of blockade.
About the Authors
N. V. ChubchenkoRussian Federation
Post Graduate Student of Anesthesiology and Intensive Care Department
K. M. Lebedinskiy
Russian Federation
Doctor of Medical Sciences, Professor, Head of Vanevsky Anesthesiology and Intensive Care Department
References
1. Grachev S.S., Skryagin А.E., Rovdo I.M. Monitoring nervno-myshechnogo bloka v anesteziologii. uch.-metod. posobie. [Monitoring of neuromuscular block in anesthesia. Handbook]. Minsk, BGMU Publ., 2012, 23 p.
2. Magomedov M.А., Zabolotskikh I.B. Mioplegia. [Myoplegia]. Moscow, Prakticheskaya Meditsina Publ., 2010, 224 p.
3. Recommendations for standards of monitoring during anesthesia and recovery. Vestnik Anasteziol. i Reanimatol., 2011, no. 5, pp. 66-70. (In Russ.)
4. Albuquerque E.X., Alkondon M., Pereira E.F., Castro N.G. Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J. Pharmacol. Exp. Ther., 1997, vol. 280, no. 3, pp. 1117-1136.
5. Association of Anaesthetists of Great Britain and Ireland. Recommendations for standards of monitoring during anaesthesia and recovery 2015. Anaesthesia, 2016, vol. 71, pp. 85-93.
6. Bialos M.T., Eisenkraft J.B. Depolarizing neuromuscular blockade. In: Clinical Cases in Anesthesia. Ed. A.P. Reed. 4th ed., Philadelphia, Elsevier, 2014, pp. 94-98.
7. Bittner E.A., Jeevendra Martyn J.A. Neuromuscular physiology and pharmacology. In: Pharmacology and Physiology for Anesthesia. Foundations and Clinical Application. Ed. H.C. Hemmings. Philadelphia, Elsevier, 2013, pp. 309-324.
8. Bowman W.C. Prejunctional and postjunctional cholinoceptors at the neuromuscular junction. Anesth. Analg., 1980, vol. 59, pp. 935-943.
9. Brull S.J., Silverman D.G., Naguib M. Monitoring neuromuscular blockade. In: Anesthesia Equipment: Principles and Applications. Ed. J. Ehrenwerth. 2nd ed., Philadelphia, Elsevier, 2013, pp. 307-327.
10. Caldwell J.E., Laster M.J., Magorian T. et al. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans. Anesthesiology, 1991, vol. 74, pp. 412-418.
11. Dilger J.P., Vidal A.M., Mody H.I., Liu Y. Evidence for direct actions of general anesthetics on an ion channel protein: a new look at a unified mechanism of action. Anesthesiology, 1994, vol. 81, pp. 431-432.
12. Donati F. Residual paralysis: a real problem or did we invent a new disease? Can. J. Anaesth., 2013, vol. 60, no. 7, pp. 714-729.
13. Drenck N.E., Ueda N., Olsen N.V., Engbaek J. Manual evaluation of residual curarization using double burst stimulation: a comparison with train-of-four. Anesthesiology, 1989, vol. 70, pp. 578-581.
14. Farooq K., Hunter J.M. Neuromuscular blocking agents and reversal agents. Anaest. Intens. Care Med., 2014, vol. 15, no. 6, pp. 295-299.
15. Fogdal R.P., Miller R.D. Neuromuscular effects of enflurane, alone and combined with d-tubocurarine, pancuronium, and succinylcholine, in man. Anesthesiology, 1975, vol. 42, pp. 173-178.
16. Fuchs-Buder T. Neuromuscular monitoring in clinical practice and research. Heidelberg, Springer, 2010, 209 p.
17. Gage P.W. Ion channels and postsynaptic potentials. Biophys. Chem., 1988, vol. 29, pp. 95-101.
18. Gage P.W., Hamill O.P. Effects of anesthetics on ion channels in synapses. Int. Rev. Physiol., 1981, vol. 25, pp. 1-45.
19. Hemmerling T.M., Donati F. Neuromuscular blockade at the larynx, the diaphragm and the corrugator supercilii muscle: a review. Can. J. Anaesth., 2003, vol. 50, no 8, pp. 779-794.
20. Hemmerling T.M., Donati F., Beaulieu P., Babin D. Phonomyography of the corrugator supercilii muscle: signal characteristics, best recording site and comparison with acceleromyography. Br. J. Anaesth., 2002, vol. 88, pp. 389-393.
21. Hemmerling T.M., Le N. Brief review: Neuromuscular monitoring: an update for the clinician. Can. J. Anaesth., 2007, vol. 54, no. 1, pp. 58-72.
22. Hemmerling T.M., Michaud G., Trager G., Deschamps S. Phonomyography and mechanomyography can be used interchangeably to measure neuromuscular block at the adductor pollicis muscle. Anesth. Analg., 2004, vol. 98, no. 2, pp. 377-381.
23. Huynh-Moynot S., Moynot J.C., Thill C., Commandeur D. Prolonged curarisation following succinylcholine injection on butyrylcholinesterase deficiency and potentiated by a lithium treatment: a case report. Ann. Biol. Clin. (Paris), 2013, vol. 71, no. 4, pp. 485-488.
24. Jeevendra Martyn J.A. Neuromuscular physiology and pharmacology. In: Miller's Anesthesia. Ed. R.D. Miller. 8th ed. Philadelphia, Elsevier, 2015, pp. 423-443.
25. Judge S.E. Effect of general anaesthetics on synaptic ion channels. Br. J. Anaesth., 1983, vol. 55, no. 3, pp. 191-200.
26. Jurkolow G., Fuchs-Buder T., Lemoine A., Raft J. Prolonged phase II neuromuscular blockade following succinylcholine administration. Ann. Fr. Anesth. Reanim., 2014, vol. 33, no. 3, pp. 176-177.
27. Kelly R.E., Lien C.A., Savarese J.J. et al. Depression of neuromuscular function in a patient during desflurane anesthesia. Anesth. Analg., 1993, vol. 76, no. 4, pp. 868-871.
28. Kopman A.F., Kumar S., Klewicka M.M., Neuman G.G. The staircase phenomenon: implications for monitoring of neuromuscular transmission. Anesthesiology, 2001, vol. 95, no. 2, pp. 403-407.
29. Lee S., Han J.W., Kim E.S. Butyrylcholinesterase deficiency identified by preoperative patient interview. Korean J. Anesthesiol., 2013, vol. 65 (6 Suppl.), pp. 1-3.
30. Liang S.S., Stewart P.A., Phillips S. An ipsilateral comparison of acceleromyography and electromyography during recovery from nondepolarizing neuromuscular block under general anesthesia in humans. Anesth. Analg., 2013, vol. 117, no. 2, pp. 373-379.
31. Locks G. de F., Cavalcanti I.L., Duarte N.M. et al. Use of neuromuscular blockers in Brazil. Braz. J. Anesthesiol., 2015, vol. 65, no. 5, pp. 319-325.
32. Maelicke A., Coban T., Storch A., Schrattenholz A. Allosteric modulation of Torpedo nicotinic acetylcholine receptor ion channel activity by noncompetitive agonists. J. Recept. Signal. Transduct. Res., 1997, vol. 17, no. 1-3, pp. 11-28.
33. Mancuso A.J. Succinylcholine side effects. In: Faust's Anesthesiology Review. Ed. M.J. Murray. 4th ed. Philadelphia, Elsevier, 2015, pp. 177-179.
34. Miller R.D., Eger E.I. 2nd, Way W.L., Stevens W.C. Comparative neuromuscular effects of Forane and halothane alone and in combination with d-tubocurarine in man. Anesthesiology, 1971, vol. 35, no. 1, pp. 38-42.
35. Miller R.D., Ward T.A. Monitoring and pharmacologic reversal of a nondepolarizing neuromuscular blockade should be routine. Anesth. Analg., 2010, vol. 111, no. 1, pp. 3-5.
36. Murphy G.S. Residual neuromuscular blockade: incidence, assessment, and relevance in the postoperative period. Minerva Anestesiol., 2006, vol. 72, no. 3, pp. 97-109.
37. Murphy G.S., Brull S.J. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesth. Analg., 2010, vol. 111, no. 1, pp. 120-128.
38. Naguib M., Kopman A.F., Lien C.A., Hunter J.M. A survey of current management of neuromuscular block in the United States and Europe. Anesth. Analg., 2010, vol. 111, no. 1, pp. 110-119.
39. Neubig R.R., Boyd N.D., Cohen J.B. Conformations of Torpedo acetylcholine receptor associated with ion transport and desensitization. Biochemistry, 1982, vol. 21, no. 14, pp. 3460-3467.
40. Nilsson E., Muller K. Neuromuscular effects of isoflurane in patients with myasthenia gravis. Acta Anaesthesiol. Scand., 1990, vol. 34, pp. 126-131.
41. Nilsson E., Paloheimo M., Muller K., Heinonen J. Halothane induced variability in the neuromuscular transmission of patients with myasthenia gravis. Acta Anaesthesiol. Scand., 1989, vol. 33, pp. 395-401.
42. Nitahara К., Sugi Y., Higa K., Shono S. Neuromuscular effects of sevoflurane in myasthenia gravis patients. Br. J. Anaesth., 2007, vol. 98, no. 3, pp. 337-341.
43. Rosenberg H. Malignant Hyperthermia (MH) and Other Anesthetic-Induced Myodystrophies (AIM). In: Essence of Anesthesia Practice. Ed. L. A. Fleisher. 3rd ed., Philadelphia, Elsevier, 2011, pp. 232-233.
44. Standaert F.G. Doughnuts and holes: molecules and muscle relaxants. Can. J. Anaesth., 1987, vol. 34, no. 1, pp. 21-29.
45. Stanec A., Heyduk J., Stanec G., Orkin L.R. Tetanic fade and post-tetanic tension in the absence of neuromuscular blocking agents in anesthetized man. Anesth Analg., 1978, vol. 57, no. 1, pp. 102-107.
46. Stewart P.A., Freelander N., Liang S. et al. Comparison of electromyography and kinemyography during recovery from non-depolarising neuromuscular blockade. Anaesth. Int. Care, 2014, vol. 42, no. 3, pp. 378-384.
47. Trager G., Michaud G., Deschamps S., Hemmerling T.M. Comparison of phonomyography, kinemyography and mechanomyography for neuromuscular monitoring. Can. J. Anaesth., 2006, vol. 53, no. 2, pp. 130-135.
48. Viby-Mogensen J. Neuromuscular monitoring. In: Anesthesia. Ed. R.D. Miller, 5th ed. New York, Churchill Livingstone, 2000, pp. 1351-1366.
49. Yasuda N., Targ A. G., Eger E.I.II. Solubility of I-653, sevoflurane, isoflurane and halothane in human tissues. Anesth. Analg., 1989, vol. 69, pp. 370-373.
Review
For citations:
Chubchenko N.V., Lebedinskiy K.M. MONITORING OF VARIOUS TYPES OF NEUROMUSCULAR BLOCKADE. Messenger of ANESTHESIOLOGY AND RESUSCITATION. 2016;13(6):64-71. (In Russ.) https://doi.org/10.21292/2078-5658-2016-13-6-64-71